Metacrine, Inc. Profile Avatar - Palmy Investing

Metacrine, Inc.

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative …

Biotechnology
US, San Diego [HQ]

Income Statements

Loading...
End of MTCR's Analysis
CIK: 1634379 CUSIP: 59101E103 ISIN: US59101E1038 LEI: - UEI: -
Secondary Listings
MTCR has no secondary listings inside our databases.